Heart failure after myocardial infarction: incidence and predictors

Aims The aim of the present paper was to provide an up-to-date view on epidemiology and risk factors of heart failure (HF) development after myocardial infarction. Methods and results Based on literature review, several clinical risk factors and biochemical, genetic, and imaging biomarkers were identified to predict the risk of HF development after myocardial infarction. Conclusions Heart failure is still a frequent complication of myocardial infarction. Timely identification of subjects at risk for HF development using a multimodality approach, and early initiation of guideline-directed HF therapy in these patients, can decrease the HF burden.

Automated summary

Heart failure remains a common complication of myocardial infarction. Timely identification of at-risk individuals and early initiation of guideline-directed therapy can reduce the burden of heart failure.